✨
AI Summary
- GLP-1 analogs are key for diabetes and obesity treatment, with rapid market growth.
- New oral, combination, and long-acting formulations are emerging.
- 19 companies are developing 46 innovative GLP-1 analog treatments.
Guests on This Episode
VG
von GLP
1 podcast appearance